Anticorps Polyclonal de lapin anti-PLOD2

• Phare
• Validé par KD/KO

PLOD2 Polyclonal Antibody for FC (Intra)

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

FC (Intra)

Conjugaison

PE Fluorescent Dye

N° de cat : PE-21214

Synonymes

PLOD2-Specific, EC:1.14.11.4, Lysyl hydroxylase 2, PLOD2/LH2, Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2

---

Galerie de données de validation

• 

  FC experiment of HeLa using PE-21214

  1x10^6 HeLa cells were intracellularly stained with 0.4 ug PE-conjugated PLOD2 Polyclonal antibody (PE-21214)(red), or 0.4 ug Isotype Control (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Applications testées

• Résultats positifs en FC (Intra): cellules HeLa,

Dilution recommandée

• Flow Cytometry (FC) (INTRA): FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Informations sur le produit

PE-21214 cible PLOD2 dans les applications de FC (Intra) et montre une réactivité avec des échantillons Humain, rat, souris

• Réactivité: Humain, rat, souris
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: PLOD2 Protéine recombinante Ag15614
• Nom complet: procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
• Masse moléculaire calculée: 758 aa, 85 kDa
• Poids moléculaire observé: 87 kDa
• Numéro d’acquisition GenBank: BC037169
• Symbole du gène: PLOD2
• Identification du gène (NCBI): 5352
• Conjugaison: PE Fluorescent Dye
• Excitation/Emission maxima wavelengths: 496 nm, 565 nm / 578 nm
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS with 0.09% sodium azide and 0.5% BSA
• Conditions de stockage: Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. 20ul contiennent 0,1% de BSA.

Informations générales

PLOD2, also named as LH2, forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. It is a potential novel prognostic factor for HCC patients following surgery. Among the PLOD genes, PLOD2 contributes to cancer prognosis and angiogenesis. Several authors have reported that PLOD2 expression might provide prognostic information about malignant tumours such as glioblastoma. PLOD2 expression is a useful biomarker for the effects of antiangiogenic treatment for malignancy. (PMID:22098155). It has 2 isoforms produced by alternative splicing and seven glycosylation sites.This antibody is specific to PLOD2.

{{ptg:RelatedPrimaryAntibodies}}